Securities Times e Company Newsmortalkombatminiarcade, Junda Shares (002865...
2024-05-19 1
Tonghuashun (300033) Financial Research Center, May 07katrinabookmancasino, some investors asked Jincheng Pharmaceutical (300233)(300233), what products are synthetic biology currently generating revenue for your company, and what products will be put into production in the future?
The company replied, Hello, investors! The company has been deeply engaged in the field of synthetic biology for many years, has built an internationally leading synthetic biology industrialization platform, and has successfully implemented biosynthetic products such as glutathione, adenosylmethionine, astaxanthin, and PQQ, as well as 4-AA, nicotine, etc. Enzyme catalyzed products. The company has established close industry-university-research cooperation and platform co-construction with authoritative teams in the field, forming a complete synthetic biology industry chain from upstream research and development, pilot scale expansion to industrialization. Currently, there are many products under research, and the company will actively promote the progress of product research and development to achieve industrialization as soon as possible. Thank you for your attention to the company!
相关文章
Securities Times e Company Newsmortalkombatminiarcade, Junda Shares (002865...
2024-05-19 1
News summary Lutian Chemical Company, Ningxia Hening Chemica...
2024-05-19 2
[global Financial Comprehensive report] Hong Kong stocks have made a counte...
2024-05-19 2
In the world of stock marketsgovernorofpoker3youdagamesThe law of supply an...
2024-05-19 2
Theme: 2024 Fund High-Quality Development Conference: Hundreds of big names...
2024-05-19 2
Car asSupermarioarcademachineAn important means of transportation in our da...
2024-05-19 2
thematicbaccaratbunny: 2024 Fund High-Quality Development Conference: Hundr...
2024-05-19 2
Theme: 2024 Fund High-Quality Development Conference: Hundreds of big names...
2024-05-18 2
最新评论